middle.news
AdAlta Partner Gains Approval for CAR-T Therapy in China’s Boao Lecheng Zone
9:30am on Wednesday 2nd of September, 2026 AEST
•
Biotechnology
Read Story
AdAlta Partner Gains Approval for CAR-T Therapy in China’s Boao Lecheng Zone
9:30am on Wednesday 2nd of September, 2026 AEST
Key Points
SHcell approved to treat advanced mesothelioma in Boao Lecheng
Therapy uses first-generation manufacturing; faster process planned for Australia
Approval based on independent safety and efficacy assessment
Treatment at Ruijin Hospital, a top-tier facility in Hainan
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
AdAlta (ASX:1AD)
OPEN ARTICLE